| ID | 119174 |
| 著者 |
板東, 浩
Medical Research|Tokushima University|Japan Low Carbohydrate Diet Promotion Association|Yoshinogawa Hospital
KAKEN研究者をさがす
Kobayashi, H
Yoshinogawa Hospital
Ogawa, H
Yoshinogawa Hospital
Nakanishi, M
Yoshinogawa Hospital
Watanabe, O
Yoshinogawa Hospital
|
| キーワード | imeglimin (Twymeeg)
pre-prandial blood glucose
post-prandial blood glucose
Trials of IMeglimin for Efficacy and Safety (TIMES)
oral hypoglycemic agent (OHA)
|
| 資料タイプ |
学術雑誌論文
|
| 抄録 | As recent topic for oral hypoglycemic agent (OHA), imeglimin (Twymeeg) shows clinical efficacy. Current case is 77-year-old female with type 2 diabetes (T2D) for years. HbA1c increased to 8.4% in Jan, 2023 and then Twymeeg was initiated. She has continued detail measurement of pre-prandial glucose 3 times a day, and these data were analyzed during Dec 2022 to Feb 2023. As a result, HbA1c decreased to 7.9% in 5 weeks, and pre-prandial level has decreased in satisfactory degree. In contrast, she kept intake of certain amount of carbohydrates in 3 meals as usual, and post-prandial hyperglycemia has been stable.
|
| 掲載誌名 |
International Journal of Endocrinology and Diabetes
|
| ISSN | 26943875
|
| 出版者 | Pubtexto Publishers
|
| 巻 | 6
|
| 号 | 1
|
| 開始ページ | 147
|
| 発行日 | 2023-03-11
|
| 権利情報 | This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
|
| 出版社版DOI | |
| 出版社版URL | |
| フルテキストファイル | |
| 言語 |
eng
|
| 著者版フラグ |
出版社版
|
| 部局 |
医学系
病院
|
